New Study Links Daily Orange Consumption to Lipid Changes in Fatty Liver Disease

Can something as simple as an orange quietly nudge your liver health in the right direction?

A recent study published in Nutrients explored whether eating “Navelina” oranges daily could improve fat metabolism in people with metabolic dysfunction-associated steatotic liver disease. This condition, closely linked to obesity and Type 2 diabetes, is driven by disruptions in how the body processes fats, increasing the risk of inflammation and long-term liver damage.

In the study, 60 adults with MASLD were divided into two groups. One group consumed 400 grams of oranges daily for four weeks, while the other avoided them. Researchers then analyzed blood samples to track changes in lipid profiles—essentially how fats circulate and behave in the body.

The results were subtle but interesting. While there were no statistically significant changes, participants who ate oranges showed a consistent trend toward improvement. Levels of “bad” cholesterol (LDL) and total cholesterol decreased slightly, while “good” cholesterol (HDL) increased. There were also small shifts in fatty acids, including a reduced ratio of pro-inflammatory compounds, hinting at a move toward a healthier, less inflammatory profile.

These effects may be linked to the natural compounds found in oranges, particularly polyphenols and fiber, which are known to influence fat metabolism and inflammation. However, researchers caution that the findings are preliminary. The study was short—just four weeks—and involved a relatively small group, meaning stronger conclusions cannot yet be drawn.

Still, the results add to growing evidence that diet plays a powerful role in managing metabolic diseases.

While oranges alone are not a treatment, they could become part of a broader dietary strategy for supporting liver health. Larger and longer-term studies will be needed to confirm whether this citrus habit can deliver meaningful clinical benefits.

REFERENCE: Nunzio, V. D., Pinto, G., Guido, D., Caruso, E. A., Cofano, M., Saponara, I., Centonze, M., Refolo, M. G., & Notarnicola, M. (2026). Effect of 4-Week Consumption of “Navelina” Oranges on Serum Lipid Profile in Patients with MASLD: Evidence from a Randomized Clinical Trial. Nutrients. 18(8). DOI: https://doi.org/10.3390/nu18081254. https://www.mdpi.com/2072-6643/18/8/1254